Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intepirdine monotherapy in mild to moderate Alzheimer's disease
NCT00224497Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of intepirdine in Alzheimer's disease (AD), sponsored by GSK. Started Sep 2005; status: completed.
02
Drugs
intepirdine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00224497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00224497.